Myocyte enhancer factor 2D provides a cross-talk between chronic inflammation and lung cancer

Macrophages, Inflammation, and Lung Cancer

(2016) Emma M. Conway et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

New biomarkers and therapeutics can be discovered during COPD-lung cancer transition

(2016) Xiangdong Wang   CELL BIOLOGY AND TOXICOLOGY

Pro-phagocytic Effects of Thymoquinone on Cigarette Smoke-exposed Macrophages Occur by Modulation of the Sphingosine-1-phosphate Signalling System

(2016) Jameel Barnawi et al.   COPD-Journal of Chronic Obstructive Pulmonary Disease

Redox Imbalance in Lung Cancer of Patients with Underlying Chronic Respiratory Conditions

(2016) Mercé Mateu-Jiménez et al.   MOLECULAR MEDICINE

COPD promotes migration of A549 lung cancer cells: the role of chemokine CCL21

(2016) Barbara Kuznar-Kaminska et al.   International Journal of Chronic Obstructive Pulmonary Disease

Relationships between chronic obstructive pulmonary disease and lung cancer: biological insights

(2016) Esther Barreiro et al.   Journal of Thoracic Disease

Targeting roles of inflammatory microenvironment in lung cancer and metastasis

(2015) Lin Shi et al.   CANCER AND METASTASIS REVIEWS

MEF2D overexpression contributes to the progression of osteosarcoma

(2015) Haichi Yu et al.   GENE

Transcription factor myocyte enhancer factor 2D regulates interleukin-10 production in microglia to protect neuronal cells from inflammation-induced death

(2015) Shaosong Yang et al.   Journal of Neuroinflammation

Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities

(2015) Ivan Bernardo et al.   PHARMACOLOGY & THERAPEUTICS

miR-218 suppressed the growth of lung carcinoma by reducing MEF2D expression

(2015) Lei Song et al.   TUMOR BIOLOGY

Overexpression of the Transcription Factor MEF2D in Hepatocellular Carcinoma Sustains Malignant Character by Suppressing G2-M Transition Genes

(2014) L. Ma et al.   CANCER RESEARCH

Alternative Splicing of MEF2C pre-mRNA Controls Its Activity in Normal Myogenesis and Promotes Tumorigenicity in Rhabdomyosarcoma Cells

(2014) Meiling Zhang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Enhanced frequency and potential mechanism of B regulatory cells in patients with lung cancer

(2014) Jiebai Zhou et al.   Journal of Translational Medicine

Oleanolic acid suppresses the proliferation of lung carcinoma cells by miR-122/Cyclin G1/MEF2D axis

(2014) Xiaoming Zhao et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling

(2014) X L Bai et al.   ONCOGENE

MEF2 transcription factors promotes EMT and invasiveness of hepatocellular carcinoma through TGF-β1 autoregulation circuitry

(2014) Wei Yu et al.   TUMOR BIOLOGY

Oxidative stress and inflammation in the normal airways and blood of patients with lung cancer and COPD

(2013) Esther Barreiro et al.   FREE RADICAL BIOLOGY AND MEDICINE

MEF2 Is a Converging Hub for Histone Deacetylase 4 and Phosphatidylinositol 3-Kinase/Akt-Induced Transformation

(2013) Eros Di Giorgio et al.   MOLECULAR AND CELLULAR BIOLOGY

Loss of MEF2D expression inhibits differentiation and contributes to oncogenesis in rhabdomyosarcoma cells

(2013) Meiling Zhang et al.   Molecular Cancer

Pathways associated with reduced quadriceps oxidative fibres and endurance in COPD

(2012) Samantha A. Natanek et al.   EUROPEAN RESPIRATORY JOURNAL

Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population

(2012) JING ZHANG et al.   RESPIROLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation

(2008) Peter R Wilker et al.   NATURE IMMUNOLOGY